Health ❯ Healthcare

Pediatric Medicine

Childhood Cancer Gender Dysphoria Rare Diseases Child Health Oncology Congenital Disorders Hormonal Treatments Pediatric Oncology Neuro-Oncology Endocrinology

FDA Expands Casgevy Gene Therapy to Children Ages Two and Up

Earlier treatment could reduce lasting organ damage, requiring regulators and clinicians to monitor long-term safety, durability and access.

Regulator Agrees Minimum Ages for UK Puberty‑Blocker Trial but Recruitment Remains Paused

Barcelona Team Performs First In‑Utero Repair of Severe Gastroschisis in Europe

Novo Nordisk’s Oral Semaglutide Lowers HbA1c in Teens in Pivotal Trial

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

Zolgensma Given to SMA Infant in Hyderabad After Minister Helps Close Funding Gap

Roche Starts Placebo-Controlled Phase 3 Trial of Elevidys to Pursue EU Approval

Injectable Microgel Shows Promise for Reducing Surgical Bleeding in Infants

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Peer-Reviewed Study Shows Lab-Grown Oesophagus Restores Swallowing in Pigs

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

Two More Patients Show Paralysis After Spinal Chemotherapy at Saitama Children’s Hospital

Plastic Surgeons Urge Delay of Youth Gender Surgeries as AMA Signals Support

Kerala Infant’s Organs Save Multiple Children as Case Highlights Rare Pediatric Donation

Mumbai Doctors Report India’s First Pediatric Liver Auto-Transplant After Ex‑Situ Tumor Resection

NHS Pathways Trial on Puberty Blockers Confronts Legal Challenge and Petition Pressure

Madrid Surgeons Save 7-Year-Old’s Leg With Donor Tibia in 3D-Guided Cancer Operation

Cross-Party MPs Urge Wes Streeting to Halt Puberty Blocker Trial as High Court Challenge Is Filed

DBV Peanut Allergy Patch Succeeds in Pivotal Phase 3, Setting Up 2026 FDA Filing